Thomas Hafner

Thomas Hafner is a seasoned entrepreneur and leader with extensive experience in the healthcare and technology sectors. As a co-founder of OpenServ since January 2024, Thomas aims to maximize the potential of AI for societal benefit. In addition, Thomas has been the co-founder and CEO of Onya Therapeutics since February 2020, driving the development of innovative wound care treatments. In a similar capacity, Thomas serves as co-founder and chairman at Mariposa Therapeutics and InQpharm, focusing on novel therapies for keratin-related diseases and advancing market-leading technologies, respectively. As the founder of Mootral, Thomas addresses climate change and antimicrobial resistance in agriculture. In a strategic role at Zaluvida Ventures, Thomas fosters life science innovations to meet global health needs, while also leading Neem Biotech Limited as chairman, where the focus is on drug discovery and combatting antibacterial resistance. Thomas's earlier career includes significant leadership roles at Prosanita Healthcare Ltd and Neuner's International.